Armstrong, A.W. , Lebwohl, M. , Warren, R.B. , Sofen, H. , Morita, A. , Imafuku, S. , Ohtsuki, M. , Spelman, L. , Passeron, T. , Papp, K.A. , Colombo, M.J. , Vaile, J. , Vritzali, E. , Hoyt, K. , Daamen, C. , Banerjee, S. , Strober, B. , Thaçi, D. and Blauvelt, A. 2024. Deucravacitinib in Plaque Psoriasis: 4-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. SKIN The Journal of Cutaneous Medicine. 8, 4 (Jul. 2024), s406. DOI:https://doi.org/10.25251/skin.8.supp.406.